Wacker Biotech and RNAV8 Bio are collaborating to revolutionize mRNA-based therapies. Wacker Biotech brings expertise in pDNA/mRNA manufacturing and lipid nanoparticle (LNP) formulation. RNAV8 Bio specializes in optimizing noncoding mRNA…
A strategic partnership between Wacker Biotech and RNAV8 Bio aims to revolutionize mRNA-based therapies. The collaboration focuses on optimizing untranslated regions (UTRs) in mRNA strands to enhance drug effectiveness. Improved…
Jill Angelo transitions from Unified Women’s Healthcare, leaving a legacy in menopause health awareness and telehealth services with Gennev. Aurion Biotech advances in cell therapies for eye diseases, bolstered by…
The biotech sector faced significant challenges, causing stocks like Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics to plummet. Biohaven's stock decreased by 35.3% due to disappointing results from its bipolar disorder…
ERBC and Menarini Biotech have formed a strategic alliance to revolutionize early-stage biopharmaceutical development. This partnership bridges the gap between scientific research and clinical trials through combined expertise in non-clinical…
Biotechnology is transforming medicine with groundbreaking advancements. A new technique reprograms cells to repair or replace damaged tissues, offering hope for previously incurable diseases. This innovation represents a significant leap,…
Biotechnology is undergoing a revolution through the integration of AI and genomic editing tools like CRISPR, enabling personalized medicine. AI rapidly analyzes complex biological data, aiding in the development of…
Biotech innovation is being reshaped by the integration of cutting-edge science and entrepreneurship. CRISPR technology offers precise gene-editing, aiming to eradicate previously incurable diseases. The collaboration of artificial intelligence and…
Small and mid-size biotech firms compete with larger companies by innovating life-altering treatments amid complex challenges. IDDI, a clinical research organization, supports smaller firms by offering precision-guided trial designs and…
Small and mid-sized biotech companies are driving a revolution in the pharmaceutical industry, despite challenges in clinical trials and regulatory compliance. The biotech sector is expected to generate $50 trillion…